Fidelity Investments’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.8K | Sell |
2,510
-463
| -16% | -$1.07K | ﹤0.01% | 4677 |
|
|
2025
Q1 | $23.2K | Buy |
2,973
+1,344
| +83% | +$10.5K | ﹤0.01% | 4170 |
|
|
2024
Q4 | $7.61K | Buy |
1,629
+205
| +14% | +$957 | ﹤0.01% | 4545 |
|
|
2024
Q3 | $7.68K | Buy |
1,424
+1,339
| +1,575% | +$7.22K | ﹤0.01% | 4507 |
|
|
2024
Q2 | $750 | Sell |
85
-500
| -85% | -$4.41K | ﹤0.01% | 4822 |
|
|
2024
Q1 | $6.87K | Buy |
585
+500
| +588% | +$5.88K | ﹤0.01% | 4402 |
|
|
2023
Q4 | $957 | Hold |
85
| – | – | ﹤0.01% | 4752 |
|
|
2023
Q3 | $581 | Hold |
85
| – | – | ﹤0.01% | 4699 |
|
|
2023
Q2 | $772 | Sell |
85
-7
| -8% | -$64 | ﹤0.01% | 4752 |
|
|
2023
Q1 | $594 | Buy |
92
+83
| +922% | +$536 | ﹤0.01% | 4778 |
|
|
2022
Q4 | $57 | Buy |
+9
| New | +$57 | ﹤0.01% | 4928 |
|